Pharmacokinetics of mycophenolic acid in kidney transplant recipients treated with a low dose (1 gram/day) of mycophenolate mofetil

Journal of the Medical Association of Thailand

Volumn 86, Issue 8, 2003, Pages 766-771

  Julasareekul, Wichian ^a   Bejraputra, Ornanong ^b   Eiam Ong, Somchai ^b   Seublinvong, Tada ^b  

^a Queen Sawangwattana Hospital   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Mycophenolate Mofetil; Mycophenolic Acid; Pharmacokinetic Studies

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG METABOLISM; FEMALE; GRAFT REJECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MALE; ORGAN TRANSPLANTATION;

ADULT; AREA UNDER CURVE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID;

EID: 0141813425     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. European Mycophenolate Mofetil Co-operative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321-5.
2. Sollinger HW, US. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225-32.
3. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029-37.
4. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation 1997; 63: 39-47.
5. Mathew TH. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: Results at three years. Transplantation 1998; 65: 1450-4.
6. Kasiske BL, Vazquez MA, Harmon WE, et al. Recommendations for the out patient surveillance of renal transplant recipients. J Am Soc Nephrol 2000; 11 (Suppl 15): S1-S86.
7. Shaw LM, Kaplan B, DeNofrio D, et al. Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther Drug Monit 2000; 22: 14-9.
8. vanGelder T, Hilbrands LB, Vanrenterghem Y, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation 1999; 68: 261-6.
9. Cuttaneo D, Gaspari F, Ferrari S, et al. Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients. Clin Transplant 2001; 15: 402-9.
10. Brunet M, Martorell J, Oppenheimer E, et al. Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil. Transpl Int 2000; 13 (Suppl 1): S301-S305.
11. Mourad M, Malaise J, Eddour DC, et al. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. Clin Chem 2001; 47: 1241-8.
12. Kungsamrith T, Eiam-Ong S, Tungsanga K, Chusil S, Panomvana Na Ayudhya D. Pharmocokinetic studies of cyclosporine in oriental kidney transplantation patients. Nephrology 2001; 6: 236-42.
13. Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 1998; 34: 429-55.
14. Yeung S, Tong KL, Tsang WK, et al. Pharmacokinetic study of mycophenolate mofetil in Asian renal transplant recipients. Transplant Proc 2000; 32: 1753-4.
15. Yeung S, Tong KL, Tsang WK, et al. Determination of mycophenolate area under the curve by limited sampling strategy. Transplant Proc 2001; 33: 1052-3.